UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported)
November 6, 2002
----------------
Advanced Nutraceuticals, Inc.
-------------------------------------------------------
(Exact Name of Registrant as Specified in its Charter)
Texas
---------------------------------------------
(State or Other Jurisdiction of Incorporation)
0-26362 76-0642336
------------------------ ------------------------------------
(Commission File Number) (I.R.S. Employer Identification No.)
106 South University Blvd. #14, Denver, Colorado 80209
----------------------------------------------------------
(Address of Principal Executive Offices) (Zip Code)
(Registrant's telephone number, including area code) - (303) 722-4008
---------------------------------------------------------------------
________________________________________________________________________________
________________________________________________________________________________
INFORMATION TO BE INCLUDED IN THE REPORT
Item 5. Other Events and Regulation FD Disclosure
On November 6, 2002, the Company issued a news release, a copy of which is
attached hereto as Exhibit 99.1, and a Corporate Overview and Highlights, a copy
of which is attached hereto as Exhibit 99.2.
Item 7. Financial Statements and Exhibits.
(c) Exhibits.
99.1 News Release dated November 6, 2002.
99.2 Corporate Overview and Highlights dated November 2002.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
ADVANCED NUTRACEUTICALS, INC.
Dated: November 6, 2002 By: /s/ Jeffrey G. McGonegal
--------------------------------
Jeffrey G. McGonegal
Senior Vice President of Finance
________________________________________________________________________________